| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $270K | -24.2% |
| SG&A Expense | $2.0M | +20.2% |
| Operating Income | -$2.3M | -12.3% |
| Interest Expense | $113K | +250.5% |
| Income Tax | $0 | — |
| Net Income | -$2.7M | -33.4% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $105K | -45.0% |
| Total Assets | $317K | +17.3% |
| Current Liabilities | $3.9M | +140.3% |
| Total Liabilities | $4.2M | +54.5% |
| Stockholders' Equity | -$3.9M | -58.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +0.7% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $1.1M | -14.6% |